What to do when a GLP-1 shipment arrives warm
Medical Disclaimer: General education, not personal medical advice. No named licensed clinical reviewer has reviewed this article. Full disclaimer. See our affiliate disclosure.
If an injectable medicine arrives warm, damaged or without clear instructions, contact the pharmacy before using it. The product and actual shipping conditions matter.
At a glance
- FDA warns against using injectable GLP-1 drugs arriving warm or with insufficient refrigeration.
- Photograph the package and record delivery timing for the pharmacy.
- Do not try to restore a questionable medicine by freezing it.
Inspect the shipment before the first dose
Check the medicine name, pharmacy identification, packaging, instructions and temperature-control materials. A product that differs from the expected shipment should be clarified rather than used on the assumption that it is equivalent.
FDA’s current unapproved-GLP-1 guidance addresses poor refrigeration, fraudulent pharmacy labeling and product quality. A discount does not compensate for an unresolved quality concern.
Sources: FDA: unapproved GLP-1 drugsWegovy prescribing informationZepbound prescribing information
Get a product-specific answer
Ask the pharmacist what is known about the shipment, whether the medicine may be used under the product’s label and whether a replacement is required. Keep the package available while the issue is reviewed.
If a dose will be missed, ask the prescriber or pharmacist about the instructions for that exact medicine. Do not take extra medication when a replacement arrives.
Sources: FDA: unapproved GLP-1 drugsWegovy prescribing informationZepbound prescribing information
Sources and review boundaries
Source check dates are listed below. First-party pages support descriptions of a service’s public offer; medical references support the educational context. They do not establish an independent clinical audit of a provider. This is general education, not personal medical advice; no named licensed clinical reviewer has reviewed this article.
- FDA: unapproved GLP-1 drugsMedical or regulatory source · Source reviewed ·
- Wegovy prescribing informationMedical or regulatory source · Source reviewed ·
- Zepbound prescribing informationMedical or regulatory source · Source reviewed ·
Related Articles
- GLP-1 medicines before surgery: what to tell the anesthesia team
- Alcohol on semaglutide: risks and questions for your prescriber
- Alcohol on tirzepatide: risks and questions for your prescriber
- Semaglutide compounding pharmacies: sourcing, rules and open questions
- Tirzepatide compounding pharmacies: sourcing, rules and open questions
- Choosing Alternatives If You Cannot Take a GLP-1
By Chief Medical Correspondent. Published . Updates are recorded when content changes.